#Truvada

Three counties in the state are among 48 nationwide eligible for federal HIV resources. Here’s what’s fueling new cases in these regions.

Evidence supports new PrEP option for gay men and trans women, but there’s no consensus for other groups.

Who got what and why? NMAC’s Paul Kawata addresses criticism and breaks down the data.

Changes to the Title X program concern abortion and target Planned Parenthood. But they should alarm the HIV community.

The chairs of the HIV Medicine Association and the American Academy of HIV Medicine urge health care advice from clinicians, not lawyers.

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.

Updating previous, similar findings, researchers have now reported on 96-week data from a pair of ongoing trials.

A late-stage trial randomized people taking a stable HIV regimen to switch to Dovato or stay on their current antiretrovirals.

How true is his statement? These facts add context.

On-demand, or 2-1-1, PrEP requires taking only four doses of Truvada during the days surrounding sex.

Researchers provided an initial Truvada prescription to eligible gay and bi men and trans women at their first appointment.

Nationwide, significant proportions of PrEP-using populations do not stay on Truvada for long.

A mathematical modeling study projected the effect of routine STI screening among a population of gay and bi men on PrEP.

However, Tivicay plus Descovy was associated with greater weight gain, especially among women.

A modeling study projected the impact of various strategies for improving PrEP use among young Black gay and bi men in Illinois.